LATEST ARTICLES

STAT+: Mirati’s KRAS-blocking lung cancer drug clears safety hurdle in combination study

0

Mirati Therapeutics said Monday that its KRAS-targeting cancer drug called adagrasib combined with another immunotherapy was well-tolerated by patients with lung cancer — avoiding the serious liver side effects and treatment discontinuations that have stalled similar efforts by Amgen. The new safety data are a boost to Mirati’s efforts to expand the number of patients with KRAS-mutated lung cancer...

14 CIC Members’ Milestone Moments of 2022 — CIC

0

Founded by Brown undergrads in 2019, Providence-based Intus Care is helping health care providers deliver the best possible care to elderly patients. Intus’s powerful data analytics platform identifies patients’ risk of hospitalizations, readmissions, and chronic disease, empowering providers to make informed decisions and optimize care. 2022 has been a banner year for Intus: they established new partnerships, including...

HIStalk Interviews Matthew Condon, CEO, Bardavon Health Innovations – HIStalk

0

Matthew “Matt” Condon, JD, MBA is founder and CEO of Bardavon Health Innovations of Overland Park, KS. Tell me about yourself and the company. I’ve been in employer-driven musculoskeletal health for the  last two decades. I grew up in Iowa, went to grad school and law school, and got passionate about this space. I was fortunate post-law school...

Curbside Consult with Dr. Jayne 12/5/22 – HIStalk

0

This weekend was all about starting some end-of-year organization and making a plan for conferences and travel for 2023. I’ll be attending many of the same conferences I did this year, but might throw in a couple of new ones if the dates work out. I had mentioned after the HLTH conference that I was disappointed in...

Vial raises $67M for clinical trial tech and more digital health fundings

0

Tech-enabled contract research organization Vial announced last week it raised $67 million in Series B funding. The round, which the startup said brings its total raise to more than $100 million, was led by General Catalyst with participation from Byers Capital, BoxGroup and other investors. Vial offers three technology platforms for running clinical trials: one for onboarding patients and launching the...

Intel Labs & Penn Medicine Uses Privacy-Preserving AI to Identify Brain Tumors

0

What You Should Know:– Intel Labs and the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) have completed a joint research study using federated learning – a distributed machine learning (ML) artificial intelligence (AI) approach – to help international healthcare and research institutions identify malignant brain tumors.– The largest medical federated learning study to date...

Hims & Hers Appoints Dr. Knoer as First-Ever Chief Pharmacy & Innovation Officer

0

What You Should Know:– Hims & Hers Health, Inc. appoints pharmacy industry veteran Dr. Scott Knoer, Pharm.D., MS, FASHP, as the company’s first-ever Chief Pharmacy & Innovation Officer.– As Chief Pharmacy & Innovation Officer, Dr. Knoer will oversee pharmacy strategy and innovation efforts for Hims & Hers. Knoer will direct efforts to develop proprietary formulations that will make...

Psychedelics for Mental Health and Trauma

0

It’s now regular to hear about mental health struggles experienced by the average citizen to a veteran to a celebrity, but many still suffer in silence. It’s common to think of mental health and addictions as the same. For this reason, the use of psychedelics for mental health and trauma can be hard for some to imagine. While strides...

Self-Care Tips for Athletes (Or Anyone Who Loves Fitness)

0

If you’re an active person, you’re likely focused on your health. Exercise is a fantastic form of self-care that boosts your physical and mental wellbeing. But one aspect of self-care that’s often overlooked is relaxation and calm. Learning to slow down can promote your workout recovery, help you return to a calm state after workouts, and lowers stress...